A platform for preparing a sequence defined biopolymer or a protein in vitro, the platform comprising a cellular extract from a genomically recoded E. colistrain comprising a genetic knock-out mutation in release factor 1 (RF-1) or a genetic homolog thereof and the genomically recoded strain further comprising at least one additional upregulated gene product, wherein the at least one addition upregulated gene product improves energy supply, chaperone levels, translation function, ribosome recycling, or any combination thereof, and the at least one additional upregulated gene product comprises a member selected from the group consisting of ackA, ndk, pykF, cdd, dsbC, dnaK, dnaJ, crpE, tig, groS, groL, infA, infB, fusA, efp, lepA, tufB, hslR, ffr, and any combination thereof.